Literature DB >> 447820

The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.

E G Biglieri, M Schambelan.   

Abstract

Plasma 18-hydroxycorticosterone (180HB) concentration was measured in 23 patients with primary aldosteronism. After overnight recumbency, the levels were markedly elevated and were 6 times higher in patients with aldosterone-producing adenomas than in patients with hyperplasia. A value of 100 ng/dl or greater at 0800 h after overnight recumbency distinguished an adenoma from hyperplasia. There was no overlap of values, as was observed with plasma aldosterone concentration (PAC) at 0800 h and after 4 h of upright posture at 1200 h. There was a significant negative correlation between the ratio of 180HB to PAC and the potassium concentration in patients with primary aldosteronism due to hyperplasia. Potassium repletion with potassium chloride and/or spironolactone in patients with aldosterone-producing adenomas decreased the 180HB:PAC ratio by decreasing 180HB and increasing PAC. 180HB is an effective discriminator of an adenoma and may be a useful marker of the events in late aldosterone synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447820     DOI: 10.1210/jcem-49-1-87

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  [Mineralocorticoid-induced hypertension].

Authors:  J Hensen; W Oelkers
Journal:  Med Klin (Munich)       Date:  1997-05-15

2.  Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  H Witzgall; O A Müller; P C Weber
Journal:  Klin Wochenschr       Date:  1983-01-03

3.  [Clinical value of captopril test in noninvasive diagnosis of aldosterone-producing adenoma].

Authors:  B Dong; X W Ma; X H Guo; Y Gao; J Q Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

Review 4.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

5.  Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

Authors:  G T Griffing; B Berelowitz; M Hudson; R Salzman; J A Manson; S Aurrechia; J C Melby; R C Pedersen; A C Brownie
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 6.  Differential diagnosis of primary aldosteronism subtypes.

Authors:  Paolo Mulatero; Chiara Bertello; Andrea Verhovez; Denis Rossato; Giuseppe Giraudo; Giulio Mengozzi; Giorgio Limerutti; Eleonora Avenatti; Davide Tizzani; Franco Veglio
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

7.  Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.

Authors:  F Otsuka; F Otsuka-Misunaga; S Koyama; H Yamanari; T Ogura; T Ohe; H Makino
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

8.  Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: evidence for 18-hydroxycorticosterone to be a better marker than aldosterone.

Authors:  H Witzgall; G Thayil; P C Weber
Journal:  Klin Wochenschr       Date:  1982-08-16

Review 9.  Work-up of the functional adrenal mass.

Authors:  Michael D Stifelman; David M Fenig
Journal:  Curr Urol Rep       Date:  2005-02       Impact factor: 2.862

10.  Mineralocorticoid hypertension.

Authors:  Vishal Gupta
Journal:  Indian J Endocrinol Metab       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.